Showing 1 - 10 of 14
It is commonly believed that the business environment in developing countries does not allow productive technology-based entrepreneurship to flourish. In this paper, we draw on the experience of Indian software firms where entrepreneurial growth has belied these predictions. This paper argues...
Persistent link: https://www.econbiz.de/10010856323
The paper analyses the contribution of 'golden papers' - seminal works whose ideas remain as fresh and relevant today as when they were first published decades ago - and which continue to dominate academic discourse among successive generations of scholars. The authors analyse why two works...
Persistent link: https://www.econbiz.de/10010856327
The global pharmaceutical sector is highly patent intensive, and firms rely on product, process and formulation patents … products patented outside the country, can no longer produce such drugs due to the introduction of TRIPS-compliant patent … regimes in their countries. Least developed countries have an extension until 2016 to implement the pharmaceutical patent …
Persistent link: https://www.econbiz.de/10010856343
Our exploratory empirical study, based on a series of in-depth interviews and a survey of firms, searches for answers on a number of questions that deal with the role of formal contracts and intellectual property rights in the context of open innovation. We find that firms active in open...
Persistent link: https://www.econbiz.de/10010712125
The impact of patent protection on biomedical innovation has been a controversial issue. Although a "medical anti … develops a framework of analysis for the impact of patent rights on biomedical innovation in "technology follower" developing … pharmaceutical industry between November 2004 and January 2005 is used to analyze the impact of patent rights as recognized under the …
Persistent link: https://www.econbiz.de/10010712264
This paper argues that three major issues need to be addressed when examining the effects of the WTO's TRIPs agreement on capability building in developing economies. First, the agreement looks at seven instruments, which have both common as well as differing implications for capability building...
Persistent link: https://www.econbiz.de/10010712365
Unlike patents and intellectual property rights in plant genetic material, TRIPs negotiations concerning geographical indications have not entered wider public imagination. However, TRIPs negotiations in this area have been and continue to be contentious. One area of contention is the explicit...
Persistent link: https://www.econbiz.de/10010712377
The impact of patent protection on biomedical innovation has been a controversial issue. Although a “medical anti … develops a framework of analysis for the impact of patent rights on biomedical innovation in “technology follower” developing … pharmaceutical industry between November 2004 and January 2005 is used to analyze the impact of patent rights as recognized under the …
Persistent link: https://www.econbiz.de/10010712400
The focus of this paper is to find an operative definition of traditional knowledge for purposes of drug research and development. Starting out with the international debate on Art. 8(j) of the Convention on Biological Diversity, 1993 and the Agreement on Trade Related Aspects of Intellectual...
Persistent link: https://www.econbiz.de/10010712408
We use an extended version of the well-established Crepon, Duguet and Mairesse model 1998 to model the relationship between appropriability mechanisms, innovation and firm-level productivity. We enrich this model in several ways. First, we consider different types of innovation spending and...
Persistent link: https://www.econbiz.de/10011004573